Dose Ranging Study of ART621 in Subjects Diagnosed With Rheumatoid Arthritis Taking Methotrexate
Status:
Terminated
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical trial is to assess the safety, efficacy, tolerability,
immunogenicity and pharmacokinetics of 3 dose levels of ART621 in the treatment of rheumatoid
arthritis.